Embryonic expression of AMPK ? subunits and the identification of a novel ?2 transcript variant in adult heart.
Ontology highlight
ABSTRACT: AMP-activated protein kinase (AMPK), the key sensor and regulator of cellular energy status, is a heterotrimeric enzyme with multiple isoforms for each subunit (?1/? 2; ?1/?2; ?1/?2/?3). Mutations in PRKAG2, which encodes the ?2 regulatory subunit, cause a cardiomyopathy characterized by hypertrophy and conduction abnormalities. The two reported PRKAG2 transcript variants, ?2-short and ?2-long (encoding 328 and 569 amino acids respectively), are both widely expressed in adult tissues. We show that both ?2 variants are also expressed during cardiogenesis in mouse embryos; expression of the ?3 isoform was also detected unexpectedly at this stage. As neither ?2 transcript is cardiac specific nor differentially expressed during embryogenesis, it is paradoxical that the disease is largely restricted to the heart. However, a recently annotated ?2 transcript, termed ?2-3B as transcription starts at an alternative exon 3b, has been identified; it is spliced in-frame to exon 4 thus generating a protein of 443 residues in mouse with the first 32 residues being unique. It is increasingly expressed in the developing mouse heart and quantitative PCR analysis established that ?2-3B is the major PRKAG2 transcript (~60%) in human heart. Antibody against the novel N-terminal sequence showed that ?2-3B is predominantly expressed in the heart where it is the most abundant ?2 protein. The abundance of ?2-3B and its tissue specificity indicate that ?2-3B may have non-redundant role in the heart and hence mediate the predominantly cardiac phenotype caused by PRKAG2 mutations.
SUBMITTER: Pinter K  
PROVIDER: S-EPMC3477313 | biostudies-literature | 2012 Sep 
REPOSITORIES:  biostudies-literature
ACCESS DATA